Target intelligence / Profile preview

Growth factor receptor-bound protein 14 (GRB14)

Target
GRB14
Molecular classification
Adaptor protein, GRB7/10/14 family
01

Overview

Growth factor receptor-bound protein 14 (GRB14) is an adaptor protein that negatively regulates receptor tyrosine kinase (RTK) signaling, particularly insulin and insulin-like growth factor receptor pathways. It contains several functional domains, including a proline-rich region, RA domain, PH domain, BPS domain, and SH2 domain, enabling it to interact with membrane lipids and phosphorylated tyrosine residues. GRB14 modulates cell proliferation, metabolism, and possibly differentiation. It is highly expressed in liver, kidney, pancreas, testis, ovary, heart, and skeletal muscle. Phosphorylation of GRB14 can be mediated by serine and tyrosine kinases. GRB14 interacts with several RTKs and signaling proteins, including the insulin receptor, insulin-like growth factor receptor, epidermal growth factor receptor, fibroblast growth factor receptor 1, TNKS2, and CNGA1 channel subunit. By inhibiting key steps downstream of activated RTKs, GRB14 plays critical roles in physiological conditions and disease states such as diabetes and cancer. Mouse models lacking Grb14 exhibit altered lipid metabolism and changes in hepatic insulin sensitivity.

02

Mechanism of action

Inhibition or modulation of key steps downstream from activated tyrosine kinase receptors (e.g., INSR, IGF-1R), often through direct binding and steric hindrance or altered protein recruitment.

03

Biological functions

Signal transductionRegulation of receptor tyrosine kinase signalingNegative regulation of insulin signalingModulation of MAPK3 phosphorylationRegulation of PDPK1 membrane translocationRegulation of glucose uptake/metabolismRegulation of lipogenesisModulation of cGMP affinity (in photoreceptors)
04

Disease associations

DiabetesCancerMetabolic disorders
05

Safety considerations

Potential for off-target effects due to broad expression and interaction with multiple RTKsInhibition of essential growth factor signaling pathways may lead to developmental or metabolic abnormalities

Beyond the preview

Go deeper on Growth factor receptor-bound protein 14 (GRB14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Growth factor receptor-bound protein 14 (GRB14).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call